Global Veterinary/Animal Vaccines Market Insights, Forecast to 2025

Description

The market is classified into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines and other vaccines on the basis of technology.
In 2017, in terms of value, Europe is expected to account for the largest share of the global animal vaccines market, followed by North America. However, the Asia Pacific region is expected to register the highest growth during the forecast period.
The global Veterinary/Animal Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Veterinary/Animal Vaccines market based on company, product type, end user and key regions.

This report studies the global market size of Veterinary/Animal Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Veterinary/Animal Vaccines in these regions.
This research report categorizes the global Veterinary/Animal Vaccines market by top players/brands, region, type and end user. This report also studies the global Veterinary/Animal Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Zoetis
Merck Animal Health
Boehringer Ingelheim
Elanco
Virbac
Vetoquinol
Phibro Animal Health
Hester
Hipra
Idt Biologika
Biogenesis Bago
Tianjin Ringpu
China Animal Husbandry

Market size by Product
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Other Vaccines
Market size by End User
Hospitals and Clinics
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Veterinary/Animal Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Veterinary/Animal Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Veterinary/Animal Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Veterinary/Animal Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Veterinary/Animal Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Veterinary/Animal Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENT

Table of Contents

1 Study Coverage
1.1 Veterinary/Animal Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Veterinary/Animal Vaccines Market Size Growth Rate by Product
1.4.2 Live Attenuated Vaccines
1.4.3 Inactivated Vaccines
1.4.4 Toxoid Vaccines
1.4.5 Recombinant Vaccines
1.4.6 Other Vaccines
1.5 Market by End User
1.5.1 Global Veterinary/Animal Vaccines Market Size Growth Rate by End User
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Veterinary/Animal Vaccines Market Size
2.1.1 Global Veterinary/Animal Vaccines Revenue 2014-2025
2.1.2 Global Veterinary/Animal Vaccines Sales 2014-2025
2.2 Veterinary/Animal Vaccines Growth Rate by Regions
2.2.1 Global Veterinary/Animal Vaccines Sales by Regions
2.2.2 Global Veterinary/Animal Vaccines Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Veterinary/Animal Vaccines Sales by Manufacturers
3.1.1 Veterinary/Animal Vaccines Sales by Manufacturers
3.1.2 Veterinary/Animal Vaccines Sales Market Share by Manufacturers
3.1.3 Global Veterinary/Animal Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Veterinary/Animal Vaccines Revenue by Manufacturers
3.2.1 Veterinary/Animal Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 Veterinary/Animal Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 Veterinary/Animal Vaccines Price by Manufacturers
3.4 Veterinary/Animal Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Veterinary/Animal Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Veterinary/Animal Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Veterinary/Animal Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Veterinary/Animal Vaccines Sales by Product
4.2 Global Veterinary/Animal Vaccines Revenue by Product
4.3 Veterinary/Animal Vaccines Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Veterinary/Animal Vaccines Breakdown Data by End User

6 North America
6.1 North America Veterinary/Animal Vaccines by Countries
6.1.1 North America Veterinary/Animal Vaccines Sales by Countries
6.1.2 North America Veterinary/Animal Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Veterinary/Animal Vaccines by Product
6.3 North America Veterinary/Animal Vaccines by End User

7 Europe
7.1 Europe Veterinary/Animal Vaccines by Countries
7.1.1 Europe Veterinary/Animal Vaccines Sales by Countries
7.1.2 Europe Veterinary/Animal Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Veterinary/Animal Vaccines by Product
7.3 Europe Veterinary/Animal Vaccines by End User

8 Asia Pacific
8.1 Asia Pacific Veterinary/Animal Vaccines by Countries
8.1.1 Asia Pacific Veterinary/Animal Vaccines Sales by Countries
8.1.2 Asia Pacific Veterinary/Animal Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Veterinary/Animal Vaccines by Product
8.3 Asia Pacific Veterinary/Animal Vaccines by End User

9 Central & South America
9.1 Central & South America Veterinary/Animal Vaccines by Countries
9.1.1 Central & South America Veterinary/Animal Vaccines Sales by Countries
9.1.2 Central & South America Veterinary/Animal Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Veterinary/Animal Vaccines by Product
9.3 Central & South America Veterinary/Animal Vaccines by End User

10 Middle East and Africa
10.1 Middle East and Africa Veterinary/Animal Vaccines by Countries
10.1.1 Middle East and Africa Veterinary/Animal Vaccines Sales by Countries
10.1.2 Middle East and Africa Veterinary/Animal Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Veterinary/Animal Vaccines by Product
10.3 Middle East and Africa Veterinary/Animal Vaccines by End User

11 Company Profiles
11.1 Zoetis
11.1.1 Zoetis Company Details
11.1.2 Company Business Overview
11.1.3 Zoetis Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Zoetis Veterinary/Animal Vaccines Products Offered
11.1.5 Zoetis Recent Development
11.2 Merck Animal Health
11.2.1 Merck Animal Health Company Details
11.2.2 Company Business Overview
11.2.3 Merck Animal Health Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Merck Animal Health Veterinary/Animal Vaccines Products Offered
11.2.5 Merck Animal Health Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Company Business Overview
11.3.3 Boehringer Ingelheim Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Boehringer Ingelheim Veterinary/Animal Vaccines Products Offered
11.3.5 Boehringer Ingelheim Recent Development
11.4 Elanco
11.4.1 Elanco Company Details
11.4.2 Company Business Overview
11.4.3 Elanco Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Elanco Veterinary/Animal Vaccines Products Offered
11.4.5 Elanco Recent Development
11.5 Virbac
11.5.1 Virbac Company Details
11.5.2 Company Business Overview
11.5.3 Virbac Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Virbac Veterinary/Animal Vaccines Products Offered
11.5.5 Virbac Recent Development
11.6 Vetoquinol
11.6.1 Vetoquinol Company Details
11.6.2 Company Business Overview
11.6.3 Vetoquinol Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Vetoquinol Veterinary/Animal Vaccines Products Offered
11.6.5 Vetoquinol Recent Development
11.7 Phibro Animal Health
11.7.1 Phibro Animal Health Company Details
11.7.2 Company Business Overview
11.7.3 Phibro Animal Health Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Phibro Animal Health Veterinary/Animal Vaccines Products Offered
11.7.5 Phibro Animal Health Recent Development
11.8 Hester
11.8.1 Hester Company Details
11.8.2 Company Business Overview
11.8.3 Hester Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Hester Veterinary/Animal Vaccines Products Offered
11.8.5 Hester Recent Development
11.9 Hipra
11.9.1 Hipra Company Details
11.9.2 Company Business Overview
11.9.3 Hipra Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Hipra Veterinary/Animal Vaccines Products Offered
11.9.5 Hipra Recent Development
11.10 Idt Biologika
11.10.1 Idt Biologika Company Details
11.10.2 Company Business Overview
11.10.3 Idt Biologika Veterinary/Animal Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Idt Biologika Veterinary/Animal Vaccines Products Offered
11.10.5 Idt Biologika Recent Development
11.11 Biogenesis Bago
11.12 Tianjin Ringpu
11.13 China Animal Husbandry

12 Future Forecast
12.1 Veterinary/Animal Vaccines Market Forecast by Regions
12.1.1 Global Veterinary/Animal Vaccines Sales Forecast by Regions 2019-2025
12.1.2 Global Veterinary/Animal Vaccines Revenue Forecast by Regions 2019-2025
12.2 Veterinary/Animal Vaccines Market Forecast by Product
12.2.1 Global Veterinary/Animal Vaccines Sales Forecast by Product 2019-2025
12.2.2 Global Veterinary/Animal Vaccines Revenue Forecast by Product 2019-2025
12.3 Veterinary/Animal Vaccines Market Forecast by End User
12.4 North America Veterinary/Animal Vaccines Forecast
12.5 Europe Veterinary/Animal Vaccines Forecast
12.6 Asia Pacific Veterinary/Animal Vaccines Forecast
12.7 Central & South America Veterinary/Animal Vaccines Forecast
12.8 Middle East and Africa Veterinary/Animal Vaccines Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Veterinary/Animal Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Choose License Type

Checkout Inquiry Sample